Product Information
ALBUTEROL SULF 2 MG/5 ML SYRUP is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0318 per ML under NDC 70752010212. Its NADAC has been published 360 times since Nov 13, 2019.
FDA first approved this application on Sep 6, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/5mL
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752010212
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212197FDA Approved
9/6/2019
TE Code
AA
On Market Since
9/6/2019
Pharmacological Classes
Price Statistics
The NADAC for ALBUTEROL SULF 2 MG/5 ML SYRUP has been published 360 times since Nov 13, 2019, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0318 per ML |
|---|---|
| All-time high | $0.0498 (Dec 13, 2023) |
| All-time low | $0.0307 (Apr 17, 2024) |
| 52-week high | $0.0358 |
| 52-week low | $0.0318 |
| Median price | $0.0384 |
| Average price | $0.0385 |
| Largest weekly change | -29.3% (Apr 17, 2024) |
| Weeks tracked | 360 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ALBUTEROL SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ALBUTEROL SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALBUTEROL SULF 2 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for ALBUTEROL SULF 2 MG/5 ML SYRUP, manufactured by Quagen Pharmaceuticals LLC, is $0.0318 per ML (NDC 70752010212), effective Sep 30, 2026.
How has the price of ALBUTEROL SULF 2 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for ALBUTEROL SULF 2 MG/5 ML SYRUP has declined 21.2%. It has been tracked across 360 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for ALBUTEROL SULF 2 MG/5 ML SYRUP?
Since Nov 13, 2019, the NADAC for ALBUTEROL SULF 2 MG/5 ML SYRUP has ranged from a low of $0.0307 (Apr 17, 2024) to a high of $0.0498 (Dec 13, 2023), with a median of $0.0384 per ML.
Are there cheaper alternatives to ALBUTEROL SULF 2 MG/5 ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of ALBUTEROL SULF 2 MG/5 ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALBUTEROL SULF 2 MG/5 ML SYRUP?
ALBUTEROL SULF 2 MG/5 ML SYRUP (NDC 70752010212) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.